GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a prominent focus in healthcare investigation, largely due to its remarkable impact on controlling ailments such as second type diabetes and obesity. Ongoing research have demonstrated that in addition to glucose management, GLP-1 medications offer potential for heart we